We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 922 results
  1. FLI1 induces erythroleukemia through opposing effects on UBASH3A and UBASH3B expression

    Background

    FLI1 is an oncogenic transcription factor that promotes diverse malignancies through mechanisms that are not fully understood. Herein, FLI1...

    Jie Wang, Chunlin Wang, ... Yaacov Ben-David in BMC Cancer
    Article Open access 09 March 2024
  2. FLI1 regulates radiotherapy resistance in nasopharyngeal carcinoma through TIE1-mediated PI3K/AKT signaling pathway

    Background

    Radiotherapy resistance is the main cause of treatment failure in nasopharyngeal carcinoma (NPC), which leads to poor prognosis. It is...

    Enni Chen, Jiajia Huang, ... Fangyun **e in Journal of Translational Medicine
    Article Open access 22 February 2023
  3. The transcription factor Fli1 restricts the formation of memory precursor NK cells during viral infection

    Natural killer (NK) cells are innate lymphocytes that possess traits of adaptive immunity, such as memory formation. However, the molecular...

    Luke Riggan, Feiyang Ma, ... Timothy E. O’Sullivan in Nature Immunology
    Article 14 March 2022
  4. Single-cell RNA profiling identifies diverse cellular responses to EWSR1/FLI1 downregulation in Ewing sarcoma cells

    Background

    The EWSR1/FLI1 gene fusion is the most common rearrangement leading to cell transformation in Ewing sarcoma (ES). Previous studies have...

    Roxane Khoogar, Fuyang Li, ... Peter J. Houghton in Cellular Oncology
    Article 07 January 2022
  5. ASB2 is a direct target of FLI1 that sustains NF-κB pathway activation in germinal center-derived diffuse large B-cell lymphoma

    Background

    Diffuse large B-cell lymphoma (DLBCL) comprises at least two main biologically distinct entities: germinal center B-cell (GCB) and...

    Giulio Sartori, Sara Napoli, ... Francesco Bertoni in Journal of Experimental & Clinical Cancer Research
    Article Open access 11 November 2021
  6. Loss of Stag2 cooperates with EWS-FLI1 to transform murine Mesenchymal stem cells

    Background

    Ewing sarcoma is a malignancy of primitive cells, possibly of mesenchymal origin. It is probable that genetic perturbations other than EWS-FLI1...

    Marc El Beaino, Jiayong Liu, ... Patrick P. Lin in BMC Cancer
    Article Open access 02 January 2020
  7. Hypoxia and HIFs in Ewing sarcoma: new perspectives on a multi-facetted relationship

    Hypoxia develops during the growth of solid tumors and influences tumoral activity in multiple ways. Low oxygen tension is also present in the bone...

    A. Katharina Ceranski, Martha J. Carreño-Gonzalez, ... Thomas G. P. Grünewald in Molecular Cancer
    Article Open access 13 March 2023
  8. Colorectal cancer detected by liquid biopsy 2 years prior to clinical diagnosis in the HUNT study

    Background

    Colorectal cancer (CRC) is often diagnosed in advanced stages. Circulating tumour DNA (ctDNA) has been proposed as an early diagnostic...

    Siv S. Brenne, Poul Henning Madsen, ... Eivor A. Laugsand in British Journal of Cancer
    Article Open access 12 July 2023
  9. Genetically Engineered Mouse Model in Ewing Sarcoma

    Modeling Ewing sarcoma is challenging, since overexpression of EWS-FLI1 induces apoptosis and is not sufficient for tumor induction. It is therefore...
    Miwa Tanaka, Takuro Nakamura in Ewing Sarcoma
    Protocol 2021
  10. EWS-FLI1-mediated tenascin-C expression promotes tumour progression by targeting MALAT1 through integrin α5β1-mediated YAP activation in Ewing sarcoma

    Background

    The extracellular matrix has been critically associated with the tumorigenesis and progression of Ewing sarcoma (ES). However, the...

    Shaohui He, Quan Huang, ... Jianru **ao in British Journal of Cancer
    Article Open access 25 October 2019
  11. Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1/HDAC3/HSP90 signaling axis

    Abstract

    Ewing sarcoma (ES) are aggressive pediatric bone and soft tissue tumors driven by EWS-ETS fusion oncogenes, most commonly EWS-FLI1 ....

    Yan Ma, Michael Baltezor, ... Andrew K. Godwin in Journal of Molecular Medicine
    Article 25 April 2019
  12. Epigenetic Analysis in Ewing Sarcoma

    Ewing sarcoma is a highly malignant tumor characterized by a chromosomal translocation that modifies the activity of an ETS family transcription...
    Jeremy M. Simon, Nicholas C. Gomez in Ewing Sarcoma
    Protocol 2021
  13. Patients with Chromosome 11q Deletions Are Characterized by Inborn Errors of Immunity Involving both B and T Lymphocytes

    Disorders of the long arm of chromosome 11 (11q) are rare and involve various chromosomal regions. Patients with 11q disorders, including Jacobsen...

    Elise J. Huisman, A. Rick Brooimans, ... Virgil A. S. H. Dalm in Journal of Clinical Immunology
    Article Open access 28 June 2022
  14. Systems Biology Analysis for Ewing Sarcoma

    Ewing sarcoma (EwS) is a highly aggressive pediatric bone cancer that is defined by a somatic fusion between the EWSR1 gene and an ETS family member,...
    Marianyela Petrizzelli, Jane Merlevede, Andrei Zinovyev in Ewing Sarcoma
    Protocol 2021
  15. Genetic Assessment of Projected Residual Feed Consumption and Expression of Significant Candidate Genes in Duroc Pigs and Second-Generation Commercial Blends

    Residual feed intake (RFI) is one of the basic and complex feed characteristics that is economically important for livestock production. However, the...

    A. A. Belous, A. A. Sermyagin, N. A. Zinovieva in Russian Journal of Genetics
    Article 01 November 2023
  16. Class I histone deacetylases (HDAC) critically contribute to Ewing sarcoma pathogenesis

    Background

    Histone acetylation and deacetylation seem processes involved in the pathogenesis of Ewing sarcoma (EwS). Here histone deacetylases (HDAC)...

    Oxana Schmidt, Nadja Nehls, ... Günther H. S. Richter in Journal of Experimental & Clinical Cancer Research
    Article Open access 15 October 2021
  17. Molecular Approaches to Diagnosis in Ewing Sarcoma: RT-PCR

    Ewing sarcoma is a rare and aggressive tumor that affects children and young adults. Ewing sarcomas are characterized by specific chromosomal...
    Carlos Rodríguez-Martín, Javier Alonso in Ewing Sarcoma
    Protocol 2021
  18. Neomorphic DNA-binding enables tumor-specific therapeutic gene expression in fusion-addicted childhood sarcoma

    Chimeric fusion transcription factors are oncogenic hallmarks of several devastating cancer entities including pediatric sarcomas, such as Ewing...

    Tilman L. B. Hölting, Florencia Cidre-Aranaz, ... Maximilian M. L. Knott in Molecular Cancer
    Article Open access 13 October 2022
  19. Chromatin Immunoprecipitation Followed by Next-Generation Sequencing (ChIP-Seq) Analysis in Ewing Sarcoma

    ChIP-seq is the method of choice for profiling protein–DNA interactions, and notably for characterizing the landscape of transcription factor binding...
    Gwenneg Kerdivel, Valentina Boeva in Ewing Sarcoma
    Protocol 2021
  20. Extracellular vesicle-associated IGF2BP3 tunes Ewing sarcoma cell migration and affects PI3K/Akt pathway in neighboring cells

    Ewing sarcoma (EWS) is a challenging pediatric cancer characterized by vast intra-tumor heterogeneity. We evaluated the RNA-binding protein IGF2BP3,...

    Caterina Mancarella, Veronica Giusti, ... Katia Scotlandi in Cancer Gene Therapy
    Article Open access 23 June 2023
Did you find what you were looking for? Share feedback.